Enhanced in vivo activation of adoptively transferred genetically targeted T cells following cyclophosphamide chemotherapy: Initial results from a phase I clinical trial treating CLL patients with autologous CD19-targeted T cells Meeting Abstract


Authors: Brentjens, R. J.; Hollyman, D.; Park, J.; Santos, E.; Yeh, R.; Stefanski, J.; Taylor, C.; Weiss, M. A.; Filippa, D.; Riviere, I.; Sadelain, M. W.
Abstract Title: Enhanced in vivo activation of adoptively transferred genetically targeted T cells following cyclophosphamide chemotherapy: Initial results from a phase I clinical trial treating CLL patients with autologous CD19-targeted T cells
Meeting Title: 51st Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 114
Issue: 22
Meeting Dates: 2009 Dec 5-8
Meeting Location: New Orleans, LA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2009-11-20
Start Page: 1335
Language: English
ACCESSION: WOS:000272725804101
PROVIDER: wos
PUBMED: 22276299
DOI: 10.1182/blood.V114.22.3436.3436
Notes: Meeting Abstract: 3436 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Renier J Brentjens
    286 Brentjens
  2. Jae Hong Park
    356 Park
  3. Elmer B Santos
    25 Santos
  4. Michel W J Sadelain
    583 Sadelain
  5. Isabelle C Riviere
    240 Riviere
  6. Mark Weiss
    86 Weiss
  7. Daniel A Filippa
    148 Filippa
  8. Raymond Yeh
    18 Yeh
  9. Clare Taylor
    18 Taylor